Lower recommended dose but not diminished efficacy obtained in elderly patients age 75 years or older in phase I study of cisplatin and docetaxel administered by 3 consecutive weekly infusions for advanced non-small cell lung cancer

✍ Scribed by Ohe, Y; Niho, S; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Goto, K; Moriyama, E; Hosomi, Y; Uramoto, H; Kunitoh, H; Saijo, N; Nishiwaki, Y

• Book ID: 118569744
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 222 KB
• Volume: 29
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(00)80199-3